Ligand ID: DEX Drugbank ID: DB00443(Betamethasone)DB01234(Dexamethasone) Indication:Topical use (cream, lotion and ointment): for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. ;Injection: for the treatment of endocrine disorders, rheumatic D=disorders, collagen diseases, dermatologic diseases, allergic statesc, ophthalmic diseases, gastrointestinal diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, cerebral edema. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 1q2w | 3C-LIKE PROTEASE (SARSr-CoV) | 5 / 12 | ASN B 231VAL B 204LEU B 268CYH B 265THR B 225 | 1.65A | 20.50 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 1q2w | 3C-LIKE PROTEASE (SARSr-CoV) | 5 / 12 | MET B 264LEU B 205LEU B 242THR B 257ILE B 259 | 1.47A | 20.69 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 1q2w | 3C-LIKE PROTEASE (SARSr-CoV) | 5 / 12 | ASN B 231VAL B 204LEU B 268CYH B 265THR B 225 | 1.67A | 20.44 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 1q2w | 3C-LIKE PROTEASE (SARSr-CoV) | 5 / 12 | ASN B 214GLY B 2MET B 6ILE B 213LEU B 282 | 1.68A | 20.30 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 1q2w | 3C-LIKE PROTEASE (SARSr-CoV) | 5 / 12 | LEU B 0ASN B 214GLY B 2MET B 6ILE B 213 | 1.62A | 20.69 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 1q2w | 3C-LIKE PROTEASE (SARSr-CoV) | 3 / 3 | MET B 264GLN B 273TYR B 237 | 1.78A | 20.69 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 1qz8 | POLYPROTEIN 1AB (SARSr-CoV) | 4 / 6 | LEU B 88LEU A 4THR B 77VAL B 110 | 1.31A | 17.86 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 1uk3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.55A | 20.68 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 1uk3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.58A | 20.62 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 1uk3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET B 264LEU B 205LEU B 242THR B 257ILE B 259 | 1.41A | 19.88 | None | ||
![]() | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) | 1uw7 | NSP9 (SARS-COVHKU-39849) | 5 / 12 | ASN A 27GLN A 49CYH A 23THR A 24LEU A 51 | 1.67A | 20.42 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 1uw7 | NSP9 (SARS-COVHKU-39849) | 5 / 12 | ASN A 27GLN A 49CYH A 23THR A 24LEU A 51 | 1.65A | 20.42 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 1ysy | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 4 / 5 | LEU A 16MET A 54LEU A 58GLN A 21 | 1.56A | 15.59 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 1z1j | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 5 | LEU B1250MET B1264LEU B1205GLN B1244 | 1.79A | 19.88 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 1zv8 | E2 GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU J 33ASN K 10ALA K 12GLN K 15SER L 29 | 1.69A | 11.76 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 2a5k | 3C-LIKE PEPTIDASE (SARSr-CoV) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.68A | 18.87 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 2a5k | 3C-LIKE PEPTIDASE (SARSr-CoV) | 5 / 12 | MET B 264LEU B 205LEU B 242THR B 257ILE B 259 | 1.45A | 18.87 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2acf | REPLICASEPOLYPROTEIN 1AB (SARS-COVTor2) | 5 / 12 | ASN D 281GLY D 285VAL B 259ILE D 313PHE D 314 | 1.36A | 20.99 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2acf | REPLICASEPOLYPROTEIN 1AB (SARS-COVTor2) | 5 / 12 | ASN D 281GLY D 285VAL B 259ILE D 313PHE D 314 | 1.36A | 20.45 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAINREPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 5 / 12 | GLN C 24VAL C 27ARG G 85ILE C 73PHE G 97 | 1.57A | 16.94 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAINREPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 5 / 12 | LEU G 64ALA G 71GLN G 74SER D 30CYH D 37 | 1.53A | 24.00 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAINREPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 5 / 12 | GLN C 24VAL C 27ARG G 85ILE C 73PHE G 97 | 1.55A | 16.94 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAINREPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 5 / 12 | GLY D 69GLN D 68LEU D 65LEU D 22THR H 89 | 1.39A | 16.73 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAINREPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 4 / 5 | LEU B 18MET F 99LEU F 100GLN B 68 | 1.33A | 16.73 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 2amq | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.49A | 19.94 | None | ||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 2c3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 179GLN A 83MET A 162ARG A 88PHE A 181 | 1.76A | 18.21 | None | ||
![]() | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) | 2c3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 179GLN A 83MET A 162ARG A 88PHE A 181 | 1.74A | 19.87 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2c3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 179GLN A 83MET A 162ARG A 88PHE A 181 | 1.69A | 20.25 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 2c3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 179GLN A 83MET A 162ARG A 88PHE A 181 | 1.75A | 19.87 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 2cjr | NUCLEOCAPSID PROTEIN (SARS-COVTW1) | 5 / 12 | ASN C 286GLY C 285GLN C 284ARG C 260ILE C 358 | 1.71A | 17.65 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2cjr | NUCLEOCAPSID PROTEIN (SARS-COVTW1) | 5 / 12 | GLY F 296GLN F 295LEU F 353ILE E 321PHE E 316 | 1.71A | 20.00 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2d2d | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY B 124MET B 17VAL B 13ILE B 136PHE B 140 | 1.52A | 20.61 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2d2d | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY B 124MET B 17VAL B 13ILE B 136PHE B 140 | 1.51A | 20.55 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 2d2d | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | MET B 264GLN B 273TYR B 237 | 1.77A | 19.94 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 2dd8 | IGG HEAVY CHAINIGG LIGHT CHAIN (Homosapiens) | 5 / 12 | MET H 100GLY H 104GLN H 6GLN L 89LEU H 45 | 1.63A | 22.67 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 2dd8 | IGG HEAVY CHAINIGG LIGHT CHAIN (Homosapiens) | 3 / 3 | MET H 100GLN L 37TYR L 86 | 1.44A | 22.67 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 2dd8 | IGG HEAVY CHAINIGG LIGHT CHAIN (Homosapiens) | 4 / 6 | LEU H 178LEU H 175THR L 132VAL L 134 | 1.45A | 21.85 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2fav | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 5 / 12 | ASN C 100GLY C 104VAL B 78ILE C 132PHE C 133 | 1.52A | 20.97 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2fav | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 5 / 12 | ASN C 100GLY C 104VAL B 78ILE C 132PHE C 133 | 1.55A | 20.45 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 2fav | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 5 / 12 | ASN B 118LEU B 94LEU B 128CYH B 144THR B 147 | 1.73A | 22.26 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 3 / 3 | MET A 170GLN C 270TYR A 208 | 0.96A | 22.50 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 6 | LEU C 173LEU C 124PHE C 305VAL C 166 | 1.40A | 21.05 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | ASN B 263ALA B 120GLN B 123MET B 207LEU B 174 | 1.78A | 21.05 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2ga6 | ORF1A POLYPROTEIN (SARSr-CoV) | 5 / 12 | GLY S 52GLN S 53VAL S 57CYH S 46THR S 47 | 1.61A | 19.17 | None | ||
![]() | 3MNP_A_DEXA784_2 (GLUCOCORTICOIDRECEPTOR) | 2ga6 | ORF1A POLYPROTEIN (SARSr-CoV) | 4 / 6 | MET A 44LEU B 45MET B 63TYR B 96 | 1.69A | 19.17 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2ga6 | ORF1A POLYPROTEIN (SARSr-CoV) | 5 / 12 | GLY S 52GLN S 53VAL S 57CYH S 46THR S 47 | 1.60A | 19.17 | None | ||
![]() | 3MNO_A_DEXA784_2 (GLUCOCORTICOIDRECEPTOR) | 2ga6 | ORF1A POLYPROTEIN (SARSr-CoV) | 4 / 6 | MET A 44LEU B 45MET B 63TYR B 96 | 1.70A | 19.17 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 2ghv | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | LEU C 421LEU C 355PHE C 325VAL C 382 | 1.45A | 19.92 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 2ghw | ANTI-SCFV ANTIBODY,80R (Homosapiens) | 4 / 5 | LEU B 112TRP B 36MET B 83LEU B 18 | 1.73A | 21.74 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 2ghw | ANTI-SCFV ANTIBODY,80R (Homosapiens) | 5 / 12 | GLY D 110GLN D 6LEU D 81MET D 83LEU D 18 | 1.56A | 21.74 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 2gib | NUCLEOCAPSID PROTEIN (SARSr-CoV) | 4 / 5 | LEU A 353MET B 323LEU B 332GLN A 307 | 1.76A | 17.41 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2gt8 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.60A | 20.55 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2gt8 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.63A | 20.50 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 2k7x | REPLICASEPOLYPROTEIN 1AB MAINPROTEASE (SARS-COVSino1-11) | 4 / 5 | LEU A 268TRP A 218LEU A 287GLN A 273 | 1.73A | 20.16 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 2k7x | REPLICASEPOLYPROTEIN 1AB MAINPROTEASE (SARS-COVSino1-11) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.41A | 20.16 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 2k87 | NSP3 OF REPLICASEPOLYPROTEIN 1A (SARSr) | 3 / 3 | MET A 1GLN A 5TYR A 2 | 1.21A | 18.77 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2liz | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.59A | 20.72 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 2liz | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.71A | 20.16 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2liz | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.62A | 20.27 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 2op9 | REPLICASEPOLYPROTEIN 1AB(PP1AB, ORF1AB)3C-LIKE PROTEINASE(3CL-PRO, 3CLP) (SARSr-CoV) | 3 / 3 | MET B 264GLN B 273TYR B 237 | 1.77A | 18.87 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 2op9 | REPLICASEPOLYPROTEIN 1AB(PP1AB, ORF1AB)3C-LIKE PROTEINASE(3CL-PRO, 3CLP) (SARSr-CoV) | 5 / 12 | MET B 264LEU B 205LEU B 242THR B 257ILE B 259 | 1.49A | 18.87 | None | ||
![]() | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | LEU C 72ASN C 74GLY C 76MET A 330THR C 274 | 1.78A | 21.26 | None | ||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | LEU C 72ASN C 74GLY C 76MET A 330THR C 274 | 1.75A | 21.26 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2pwx | 3C-LIKE PROTEINASE (SARS-COVBJ01) | 5 / 12 | VAL A 204ARG A 131LEU A 268CYH A 265THR A 225 | 1.59A | 21.05 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 2pwx | 3C-LIKE PROTEINASE (SARS-COVBJ01) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.78A | 19.88 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2pwx | 3C-LIKE PROTEINASE (SARS-COVBJ01) | 5 / 12 | VAL A 204ARG A 131LEU A 268CYH A 265THR A 225 | 1.58A | 21.10 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.52A | 19.88 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 5 / 12 | LEU A 177GLY A 179GLN A 83ARG A 88ILE A 106 | 1.72A | 19.88 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 4 / 5 | LEU B 268TRP B 218LEU B 287GLN B 273 | 1.77A | 19.88 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 3 / 3 | MET B 264GLN B 273TYR B 237 | 1.71A | 19.88 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 2qc2 | 3C-LIKE PROTEINASE (-) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.67A | 19.88 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 2qcy | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.50A | 19.88 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 2qiq | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.50A | 19.88 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | LEU C 297MET C 209ARG C 198ILE C 306PHE C 232 | 1.68A | 21.86 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | MET A 218GLN A 259LEU A 248ILE A 222PHE A 221 | 1.76A | 21.17 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 2vj1 | MAIN PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.50A | 20.91 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 2vj1 | MAIN PROTEINASE (SARSr-CoV) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.80A | 20.91 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 2vj1 | MAIN PROTEINASE (SARSr-CoV) | 5 / 12 | ASN B 214GLY B 2ARG B 298GLN B 256LEU B 253 | 1.77A | 20.91 | None | ||
![]() | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) | 2vj1 | MAIN PROTEINASE (SARSr-CoV) | 5 / 12 | ASN A 214GLY A 2GLN A 299ARG A 298LEU A 282 | 1.74A | 20.97 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 2vj1 | MAIN PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 2GLN A 299THR A 285ILE A 286LEU A 282 | 1.59A | 20.97 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 2vj1 | MAIN PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 177GLY A 179GLN A 83ARG A 88ILE A 106 | 1.78A | 20.91 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 2w2g | NSP3 (SARSr-CoV) | 5 / 12 | GLY B 572GLN B 570MET B 557THR B 605ILE B 608 | 1.74A | 21.61 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 2w2g | NSP3 (SARSr-CoV) | 5 / 12 | GLY A 572GLN A 570MET A 557THR A 605ILE A 608 | 1.69A | 21.61 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 2w2g | NSP3 (SARSr-CoV) | 5 / 12 | GLY A 572GLN A 570MET A 557THR A 605ILE A 608 | 1.69A | 22.30 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 2xyq | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | ASN A 29GLY A 31MET A 42LEU A 239THR A 172 | 1.69A | 25.71 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 2xyq | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | ASN A 29GLY A 31MET A 42LEU A 239THR A 172 | 1.71A | 25.71 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 2xyr | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | LEU A 111ALA A 72LEU A 100CYH A 115PHE A 70 | 1.79A | 22.30 | NoneNoneSFG A1298 (-4.3A)SFG A1298 (-3.7A)None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 2xyv | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | ASN A 29GLY A 31MET A 42LEU A 239THR A 172 | 1.69A | 24.70 | NA A1295 (-3.8A)NoneNoneNone NA A1295 (-3.5A) | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 2xyv | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | ASN A 29GLY A 31MET A 42LEU A 239THR A 172 | 1.68A | 24.70 | NA A1295 (-3.8A)NoneNoneNone NA A1295 (-3.5A) | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 3atw | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.42A | 19.88 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 3avz | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 177GLY A 179GLN A 83ARG A 88ILE A 106 | 1.70A | 19.88 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 3d0g | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU E 412ALA E 422MET E 417LEU E 499PHE E 387 | 1.66A | 18.25 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 3d0h | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU E 412ALA E 422MET E 417LEU E 499PHE E 387 | 1.59A | 18.65 | None | ||
![]() | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | ASN B 290GLY B 286GLN B 287THR B 294VAL B 293 | 1.65A | 18.94 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 6 | LEU B 370TRP B 302PHE B 308THR B 362 | 1.45A | 19.28 | None | ||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | ASN B 290GLY B 286GLN B 287THR B 294VAL B 293 | 1.68A | 18.94 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 3d0i | ACE2SPIKE GLYCOPROTEIN (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | MET B 323GLY F 488GLN F 492ILE B 379PHE B 356 | 1.72A | 18.68 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 3d0i | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU E 412ALA E 422MET E 417LEU E 499PHE E 387 | 1.64A | 18.65 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 3d0i | ACE2SPIKE GLYCOPROTEIN (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | MET B 323GLY F 488GLN F 492ILE B 379PHE B 356 | 1.64A | 19.80 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 3d0i | ACE2SPIKE GLYCOPROTEIN (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | MET B 323GLY F 488GLN F 492ILE B 379PHE B 356 | 1.68A | 18.21 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 3d62 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.67A | 20.38 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 3e91 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN A 214GLY A 215LEU A 220MET A 264PHE A 3 | 1.78A | 19.50 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 3e91 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.50A | 19.50 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 3e9s | NSP3 (SARSr-CoV) | 4 / 6 | LEU A 118LEU A 133THR A 169VAL A 166 | 1.45A | 21.21 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 3ea7 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 124MET A 17VAL A 13ILE A 136PHE A 140 | 1.48A | 20.37 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 3ea7 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 124MET A 17VAL A 13ILE A 136PHE A 140 | 1.48A | 20.31 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 3eaj | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.77A | 19.50 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 3eaj | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 5 | LEU B 268TRP B 218LEU B 287GLN B 273 | 1.79A | 19.50 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 3ebn | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | MET A 264LEU C 205LEU A 242THR A 257ILE A 259 | 1.47A | 20.33 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 3ebn | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | ASN B 231VAL D 204LEU B 268CYH B 265THR B 225 | 1.64A | 20.72 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 3ebn | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | ASN B 231VAL D 204LEU B 268CYH B 265THR B 225 | 1.67A | 20.27 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 3ebn | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 3 / 3 | MET B 264GLN B 273TYR B 237 | 1.79A | 20.33 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 3f9e | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 6GLY A 124PHE A 8CYH A 128PHE A 140 | 1.51A | 19.88 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 3f9f | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | MET B 264GLN B 273TYR B 237 | 1.74A | 19.88 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 3f9f | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET B 264LEU B 205LEU B 242THR B 257ILE B 259 | 1.48A | 19.88 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.65A | 20.81 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.51A | 19.88 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.75A | 19.88 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 3f9h | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 177GLY B 179GLN B 83ARG B 88ILE B 106 | 1.78A | 19.88 | None | ||
![]() | 3MNP_A_DEXA784_2 (GLUCOCORTICOIDRECEPTOR) | 3f9h | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | LEU B 272TRP B 218MET B 276GLN B 273 | 1.72A | 20.74 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 3fzd | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLN A 19MET A 162LEU A 86ILE A 43PHE A 66 | 1.68A | 20.26 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 3fzd | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 27GLN A 19MET A 162ILE A 43PHE A 66 | 1.44A | 19.88 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 3fzd | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.48A | 19.88 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 3iwm | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 17ASN A 28GLN A 69LEU A 75CYH A 38 | 1.75A | 19.88 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 3iwm | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 177GLY B 179GLN B 83ARG B 88ILE B 106 | 1.41A | 19.88 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 3iwm | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 17ASN A 28GLN A 69LEU A 75CYH A 38 | 1.74A | 19.88 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 3iwm | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | MET B 264GLN B 273TYR B 237 | 1.72A | 19.88 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 3m3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.77A | 19.88 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 3m3t | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.52A | 19.88 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 3m3t | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.72A | 19.88 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN B 214GLY B 215LEU B 220MET B 264PHE B 3 | 1.78A | 19.50 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET B 264LEU B 205LEU B 242THR B 257ILE B 259 | 1.46A | 19.50 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.75A | 19.50 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 3r24 | 2'-O-METHYLTRANSFERASENSP10 AND NSP11 (SARSr-CoV) | 3 / 3 | MET B 63GLN A 87TYR B 96 | 1.47A | 18.02 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 3sci | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU E 412ALA E 422MET E 417LEU E 499PHE E 387 | 1.62A | 18.80 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 3scj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU E 412ALA E 422MET E 417LEU E 499PHE E 387 | 1.67A | 18.08 | None | ||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 3scj | ACE2 (Homosapiens) | 5 / 12 | LEU B 418GLN B 300MET B 366THR B 434PHE B 428 | 1.79A | 17.80 | None | ||
![]() | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) | 3scj | ACE2 (Homosapiens) | 5 / 12 | LEU B 267GLY B 272ARG B 169THR B 282VAL B 244 | 1.76A | 17.80 | NoneNone CL B 902 (-3.8A)NoneNone | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 3sck | ACE2SPIKE GLYCOPROTEIN (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | MET A 323GLY E 488GLN E 492ILE A 379PHE A 356 | 1.69A | 17.87 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 5 | LEU A 444TRP A 594LEU A 240GLN A 442 | 1.71A | 18.95 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 3sck | ACE2SPIKE GLYCOPROTEIN (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | MET A 323GLY E 488GLN E 492ILE A 379PHE A 356 | 1.65A | 17.41 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 3sck | ACE2SPIKE GLYCOPROTEIN (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | MET A 323GLY E 488GLN E 492ILE A 379PHE A 356 | 1.62A | 18.95 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | MET A 455ARG A 514PHE A 512ILE A 484PHE A 230 | 1.63A | 18.95 | None | ||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | LEU B 418GLN B 300MET B 366THR B 434PHE B 428 | 1.70A | 17.76 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 6 | LEU B 370TRP B 302PHE B 308THR B 362 | 1.44A | 18.48 | None | ||
![]() | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) | 3scl | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | LEU A 267GLY A 272ARG A 169THR A 282VAL A 244 | 1.70A | 17.76 | NoneNone CL A 902 (-4.4A)NoneNone | ||
![]() | 3MNO_A_DEXA784_2 (GLUCOCORTICOIDRECEPTOR) | 3sna | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | LEU A 272TRP A 218MET A 276GLN A 273 | 1.71A | 20.69 | None | ||
![]() | 3MNP_A_DEXA784_2 (GLUCOCORTICOIDRECEPTOR) | 3sna | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | LEU A 272TRP A 218MET A 276GLN A 273 | 1.70A | 20.63 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 4hi3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | MET B 264GLN B 273TYR B 237 | 1.77A | 20.12 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 4hi3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.42A | 20.12 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 4hi3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.64A | 20.49 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 4hi3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.61A | 20.54 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 4m0w | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | GLN A 123MET A 244LEU A 174ILE A 152PHE A 148 | 1.68A | 21.49 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 4mds | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 49MET A 82ARG A 60LEU A 87CYH A 85 | 1.76A | 19.88 | 23H A 401 (-3.8A)NoneNoneNoneDMS A 403 ( 3.7A) | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 4mds | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 177GLY A 179GLN A 83ARG A 88ILE A 106 | 1.80A | 19.88 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 4mm3 | PAPAIN-LIKEPROTEINASE (SARSr-CoV) | 5 / 12 | GLN B 123MET B 244LEU B 174ILE B 152PHE B 148 | 1.72A | 21.41 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 4mm3 | PAPAIN-LIKEPROTEINASEUBIQUITIN (Homosapiens;SARSr-CoV) | 5 / 12 | GLN A 49ARG B 167THR A 12ILE A 13LEU A 67 | 1.78A | 20.63 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 4ovz | PAPAIN-LIKEPROTEINASE (SARS-COVUrbani) | 5 / 12 | GLY A 143VAL A 99LEU A 119ILE A 152PHE A 148 | 1.57A | 21.10 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 4ow0 | PAPAIN-LIKE PROTEASE (SARS-COVUrbani) | 4 / 6 | LEU A 118LEU A 133THR A 169VAL A 166 | 1.35A | 21.30 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 4tww | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN B 214GLY B 215LEU B 220MET B 264PHE B 3 | 1.70A | 19.88 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 4tww | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN B 231VAL B 204LEU B 268CYH B 265THR B 225 | 1.58A | 20.62 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 4tww | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN B 231VAL B 204LEU B 268CYH B 265THR B 225 | 1.56A | 19.33 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 4tww | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | MET B 264GLN B 273TYR B 237 | 1.71A | 19.88 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 5b6o | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | MET B 264GLN B 273TYR B 237 | 1.76A | 20.06 | None | ||
![]() | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) | 5c8s | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | LEU B 105GLY B 93MET B 153THR B 97VAL B 101 | 1.76A | 20.73 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 5c8s | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | LEU D 411LEU D 419GLY D 413THR D 113ILE D 87 | 1.49A | 19.89 | None | ||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 5c8s | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | LEU B 105GLY B 93MET B 153THR B 97VAL B 101 | 1.74A | 20.73 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5c8s | NSP10 (SARSr-CoV) | 5 / 12 | GLY C 52GLN C 53VAL C 57CYH C 46THR C 47 | 1.51A | 16.79 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 5c8t | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | LEU D 411LEU D 419GLY D 413THR D 113ILE D 87 | 1.45A | 19.89 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5c8u | NSP10 (SARSr-CoV) | 5 / 12 | GLY C 52GLN C 53VAL C 57CYH C 46THR C 47 | 1.51A | 17.62 | None | ||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 5c8u | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | LEU D 105GLY D 93MET D 153THR D 97VAL D 101 | 1.77A | 21.77 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 5c8u | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | ASN D 334GLY D 333PHE D 426CYH D 356ILE D 338 | 1.77A | 19.89 | None | ||
![]() | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) | 5c8u | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | LEU D 105GLY D 93MET D 153THR D 97VAL D 101 | 1.79A | 21.77 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5e6j | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | GLY A 143VAL A 99LEU A 119ILE A 152PHE A 148 | 1.54A | 21.26 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5e6j | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | GLN A 123MET A 244LEU A 174ILE A 152PHE A 148 | 1.69A | 21.56 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5e6j | REPLICASEPOLYPROTEIN 1ABUBIQUITIN (SARSr-CoV;syntheticconstruct) | 5 / 12 | GLY B 47VAL B 70ARG A 167LEU B 69ILE B 61 | 1.60A | 13.41 | 5MW B 48 ( 2.4A)NoneNoneNoneNone | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5e6j | POLYUBIQUITIN-BREPLICASEPOLYPROTEIN 1AB (SARSr-CoV;syntheticconstruct) | 5 / 12 | GLY C 10VAL D 12LEU D 65THR C 14ILE C 13 | 1.42A | 13.41 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5e6j | POLYUBIQUITIN-BREPLICASEPOLYPROTEIN 1AB (SARSr-CoV;syntheticconstruct) | 5 / 12 | GLY C 10VAL D 12LEU D 65THR C 14ILE C 13 | 1.43A | 13.41 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5e6j | REPLICASEPOLYPROTEIN 1ABUBIQUITIN (SARSr-CoV;syntheticconstruct) | 5 / 12 | GLY B 47VAL B 70ARG A 167LEU B 69ILE B 61 | 1.61A | 13.41 | 5MW B 48 ( 2.4A)NoneNoneNoneNone | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 5e6j | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 6 | LEU D 118LEU D 133THR D 169VAL D 166 | 1.37A | 21.86 | None | ||
![]() | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 12 | LEU B 105GLY B 93MET B 153THR B 97VAL B 101 | 1.72A | 21.77 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 12 | GLY N 52GLN N 53VAL N 57CYH N 46THR N 47 | 1.49A | 17.18 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 12 | LEU B 411LEU B 419GLY B 413THR B 113ILE B 87 | 1.46A | 18.93 | None | ||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 12 | LEU B 105GLY B 93MET B 153THR B 97VAL B 101 | 1.70A | 21.77 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 12 | ASN C 518GLN C 513VAL C 381LEU C 321THR C 522 | 1.54A | 17.63 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 12 | GLY N 52GLN N 53VAL N 57CYH N 46THR N 47 | 1.49A | 17.74 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 12 | ASN C 518GLN C 513VAL C 381LEU C 321THR C 522 | 1.57A | 18.20 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 5r7z | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.45A | 19.50 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.77A | 19.32 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.75A | 19.32 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.66A | 19.32 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.46A | 19.29 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.69A | 19.32 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 5tl6 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 6 | LEU B 118LEU B 133THR B 169VAL B 166 | 1.45A | 21.21 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 5tl6 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | ASN B 216GLY B 210ARG B 167LEU B 186THR B 219 | 1.76A | 22.73 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5tl7 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | GLN D 123MET D 244LEU D 174ILE D 152PHE D 148 | 1.72A | 22.12 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5tl7 | UBIQUITIN-LIKEPROTEIN ISG15 (Musmusculus) | 5 / 12 | GLY A 139MET A 129VAL A 102LEU A 122THR A 145 | 1.64A | 15.12 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5x4s | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | GLN A 280LEU A 60THR A 215ILE A 272PHE A 213 | 1.67A | 21.05 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 5x4s | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | LEU A 257LEU A 194PHE A 103VAL A 254 | 1.27A | 18.98 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | ASN B1005ALA B1008GLN B 766SER B1012MET A 709 | 1.58A | 11.54 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | GLN A 280LEU A 60THR A 215ILE A 272PHE A 213 | 1.64A | 12.34 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 4 / 5 | LEU A 898MET A1032LEU A1031GLN A 895 | 1.54A | 13.06 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 3 / 3 | MET A 851GLN A 769TYR A 771 | 1.73A | 13.06 | None | ||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 5x59 | S PROTEIN (MERS-CoV) | 5 / 12 | LEU B 893GLY B1011MET B1137VAL B 898PHE B1019 | 1.64A | 11.66 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | ASN A 910GLY A 781LEU A 776ILE A 913PHE A 909 | 1.64A | 13.06 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | GLY C 780GLN C 902LEU C 898LEU C1031THR C 863 | 1.62A | 13.06 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 4 / 6 | LEU B 257LEU B 194PHE B 103VAL B 254 | 1.28A | 11.54 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | ASN A 910GLY A 781MET A 884PHE A 779ILE A 913 | 1.68A | 13.06 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 5x5f | S PROTEIN (MERS-CoV) | 5 / 6 | LEU A 234LEU A 169PHE A 239THR A 238VAL A 19 | 1.78A | 11.61 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASN A 910GLY A 781PHE A 880MET A 884ILE A 913 | 1.51A | 12.93 | ASN A 910 ( 0.6A)GLY A 781 ( 0.0A)PHE A 880 ( 1.3A)MET A 884 ( 0.0A)ILE A 913 ( 0.4A) | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 3 / 3 | MET A 851GLN A 769TYR A 771 | 1.77A | 12.93 | MET A 851 ( 0.0A)GLN A 769 ( 0.6A)TYR A 771 ( 1.3A) | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASN C 937ALA C 714GLN C 756SER C 712LEU C 930 | 1.70A | 10.80 | ASN C 937 ( 0.6A)ALA C 714 ( 0.0A)GLN C 756 ( 0.6A)SER C 712 ( 0.0A)LEU C 930 ( 0.6A) | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | LEU C1045LEU C 788THR C 863VAL C1015 | 0.98A | 10.80 | LEU C1045 ( 0.6A)LEU C 788 ( 0.6A)THR C 863 ( 0.8A)VAL C1015 ( 0.6A) | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASN B 304GLY B 580GLN B 301LEU A 749LEU A 840 | 1.68A | 12.93 | ASN B 304 ( 0.6A)GLY B 580 ( 0.0A)GLN B 301 ( 0.6A)LEU A 749 ( 0.6A)LEU A 840 ( 0.6A) | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 5y3q | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 4 / 6 | LEU A 118LEU A 133THR A 169VAL A 166 | 1.35A | 21.39 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 6acc | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU C 194GLY C 225ARG A 449ILE C 125PHE C 161 | 1.73A | 13.35 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 6acd | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASN C1005ALA C1008GLN C 766SER C1012MET A 709 | 1.50A | 10.80 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 6acd | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | MET B 882GLY C1075THR C1059ILE C 694PHE C1077 | 1.56A | 13.35 | None | ||
![]() | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6acd | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | GLY C1075GLN B 895GLN C1095THR C 894VAL C 893 | 1.71A | 10.71 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6acg | ACE2 (Homosapiens) | 4 / 5 | LEU D 444TRP D 594LEU D 236GLN D 442 | 1.71A | 19.11 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | GLY A 780GLN A 902LEU A 898LEU A1031THR A 863 | 1.47A | 13.35 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASN B 910GLN B 902MET B 884LEU B1031ILE B 913 | 1.50A | 12.76 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASN B 910GLN B 902MET B 884LEU B1031ILE B 913 | 1.54A | 12.76 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 6acg | ACE2SPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 5 / 12 | MET D 323GLY C 488GLN C 492ILE D 379PHE D 356 | 1.70A | 19.11 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 6acg | ACE2SPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 5 / 12 | MET D 323GLY C 488GLN C 492ILE D 379PHE D 356 | 1.78A | 19.11 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6acg | ACE2 (Homosapiens) | 4 / 6 | LEU D 444TRP D 594LEU D 236PHE D 588 | 1.29A | 18.32 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 5 | LEU C 898MET C1032LEU C1031GLN C 895 | 1.71A | 13.35 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 6ack | ACE2SPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 5 / 12 | MET D 323GLY C 488GLN C 492ILE D 379PHE D 356 | 1.54A | 19.11 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ack | ACE2SPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 5 / 12 | MET D 323GLY C 488GLN C 492ILE D 379PHE D 356 | 1.56A | 17.41 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | LEU A1045LEU A 788THR A 863VAL A1015 | 0.84A | 10.80 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 6ack | ACE2 (Homosapiens) | 5 / 12 | LEU D 423ALA D 413GLN D 442SER D 409MET D 297 | 1.78A | 18.32 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASN A 910GLY A 781PHE A 880MET A 884ILE A 913 | 1.39A | 13.35 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASN A 910GLN A 902MET A 884LEU A1031ILE A 913 | 1.49A | 12.85 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 6ack | ACE2SPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 5 / 12 | MET D 323GLY C 488GLN C 492ILE D 379PHE D 356 | 1.59A | 18.69 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | ASN B 910GLY B 781PHE B 880MET B 884ILE B 913 | 1.46A | 13.03 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLN B 280LEU B 60THR B 215ILE B 272PHE B 213 | 1.76A | 12.42 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | ASN B 910GLY B 781LEU B 776ILE B 913PHE B 909 | 1.76A | 13.03 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | ASN C 937ALA C 714GLN C 756SER C 712LEU C 930 | 1.67A | 10.90 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 5 | LEU C 898MET C1032LEU C1031GLN C 895 | 1.60A | 13.03 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | ASN C 304GLY C 579LEU A 843LEU A 749THR A 743 | 1.57A | 13.03 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 6 | LEU A1045LEU A 788THR A 863VAL A1015 | 1.00A | 10.90 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 3 / 3 | MET B 722GLN B 818TYR B 819 | 1.74A | 13.08 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLY B 867MET B 884LEU B1031ILE B 787PHE B 784 | 1.39A | 12.47 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 5 | LEU A 898MET A1032LEU A1031GLN A 895 | 1.73A | 13.08 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | ASN C 304GLY C 579LEU A 843LEU A 749THR A 743 | 1.48A | 13.08 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLY A1113VAL A1110THR A1102ILE A1097PHE A1077 | 1.32A | 12.56 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLY A1113VAL A1110THR A1102ILE A1097PHE A1077 | 1.31A | 12.47 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 6cs0 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLN B 112LEU B 224THR B 150ILE B 152PHE B 153 | 1.50A | 13.08 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 6cs0 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | MET C 107THR C 150ILE C 117PHE C 138LEU C 235 | 1.59A | 11.86 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6cs1 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 6 | LEU C1045LEU C 788THR C 863VAL C1015 | 0.95A | 11.19 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 6cs1 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLN C 280ARG C 620THR C 215ILE C 272PHE C 213 | 1.61A | 13.08 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 6cs2 | ACE2SPIKEGLYCOPROTEIN,FIBRITIN (Homosapiens;SARSr-CoV) | 5 / 12 | MET D 323GLY B 488GLN B 492ILE D 379PHE D 356 | 1.52A | 19.05 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 6cs2 | ACE2SPIKEGLYCOPROTEIN,FIBRITIN (Homosapiens;SARSr-CoV) | 5 / 12 | MET D 323GLY B 488GLN B 492ILE D 379PHE D 356 | 1.61A | 18.63 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 6cs2 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | ASN B 910GLY B 781PHE B 880MET B 884ILE B 913 | 1.32A | 13.08 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 6cs2 | ACE2 (Homosapiens) | 5 / 12 | MET D 455ARG D 514PHE D 512ILE D 484PHE D 230 | 1.68A | 19.05 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 6cs2 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | ASN C 937ALA C 714GLN C 756SER C 712LEU C 930 | 1.35A | 11.19 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6cs2 | ACE2SPIKEGLYCOPROTEIN,FIBRITIN (Homosapiens;SARSr-CoV) | 5 / 12 | MET D 323GLY B 488GLN B 492ILE D 379PHE D 356 | 1.59A | 17.36 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 6jyt | HELICASE (SARSr-CoV) | 5 / 12 | GLN A 404ARG A 567CYH A 309THR A 307PHE A 373 | 1.70A | 18.32 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 6jyt | HELICASE (SARSr-CoV) | 5 / 12 | GLN A 404ARG A 567CYH A 309THR A 307PHE A 373 | 1.77A | 18.32 | None | ||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6jyt | HELICASE (SARSr-CoV) | 5 / 12 | GLY A 400GLN A 404ARG A 567THR A 307VAL A 372 | 1.78A | 18.54 | None | ||
![]() | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) | 6jyt | HELICASE (SARSr-CoV) | 5 / 12 | GLN A 404MET A 378ARG A 567CYH A 309THR A 359 | 1.75A | 18.24 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 6jyt | HELICASE (SARSr-CoV) | 5 / 12 | GLY B 527THR B 547ILE B 493PHE B 511LEU B 528 | 1.63A | 18.24 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.68A | 21.85 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.70A | 22.15 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.79A | 21.85 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.77A | 22.15 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.48A | 19.50 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.77A | 19.50 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.45A | 19.50 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.79A | 21.85 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.66A | 21.85 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.69A | 22.15 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.80A | 19.50 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.77A | 22.15 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m17 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | ASN C 310GLN C 274VAL C 55LEU C 427ILE C 309 | 1.66A | 19.01 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 6m17 | ACE2RECEPTOR BINDINGDOMAIN (Homosapiens;SARS-CoV-2) | 5 / 12 | MET D 323GLY F 502GLN F 506ILE D 379PHE D 356 | 1.79A | 15.56 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m17 | ACE2RECEPTOR BINDINGDOMAIN (Homosapiens;SARS-CoV-2) | 5 / 12 | MET D 323GLY F 502GLN F 506ILE D 379PHE D 356 | 1.74A | 15.37 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 6m17 | ACE2RECEPTOR BINDINGDOMAIN (Homosapiens;SARS-CoV-2) | 5 / 12 | MET D 323GLY F 502GLN F 506ILE D 379PHE D 356 | 1.70A | 16.01 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m17 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | GLY A 438MET A 432LEU A 208THR A 466PHE A 123 | 1.74A | 19.17 | NoneLEU A 707 ( 4.7A)NoneNoneNone | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 6m18 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | LEU A 80GLY A 82MET A 502ILE A 545PHE A 276 | 1.72A | 19.49 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6m1d | ACE2SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 4 / 5 | LEU D 743TRP C 138MET C 197LEU C 199 | 1.55A | 16.01 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 6m1d | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | GLY A 66MET A 71LEU A 61ILE A 251PHE A 255 | 1.38A | 19.49 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6m1d | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | GLN C 444ARG C 447LEU C 461CYH C 463THR C 466 | 1.71A | 19.49 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6m1d | ACE2SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 4 / 6 | LEU A 140TRP A 150LEU A 415VAL B 745 | 1.31A | 17.40 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | MET D 264LEU D 205LEU D 242THR D 257ILE D 259 | 1.46A | 19.50 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.70A | 22.15 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY D 174VAL D 171CYH D 128ILE D 106PHE D 112 | 1.78A | 21.85 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.67A | 21.85 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN B 231VAL B 204LEU B 268CYH B 265THR B 225 | 1.67A | 21.85 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN B 231VAL B 204LEU B 268CYH B 265THR B 225 | 1.70A | 22.15 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY D 174VAL D 171CYH D 128ILE D 106PHE D 112 | 1.76A | 22.15 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | MET B 264LEU B 205LEU B 242THR B 257ILE B 259 | 1.45A | 19.50 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY C 174VAL C 171CYH C 128ILE C 106PHE C 112 | 1.80A | 21.85 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY B 174VAL B 171CYH B 128ILE B 106PHE B 112 | 1.79A | 22.15 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.45A | 19.50 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 3 / 3 | MET D 264GLN D 273TYR D 237 | 1.73A | 19.50 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | MET C 264LEU C 205LEU C 242THR C 257ILE C 259 | 1.55A | 19.50 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY C 174VAL C 171CYH C 128ILE C 106PHE C 112 | 1.77A | 22.15 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.68A | 22.15 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.76A | 22.15 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.79A | 21.85 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.66A | 21.85 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.79A | 19.50 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.48A | 19.50 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.66A | 13.61 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.60A | 13.61 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 212LEU A 146THR A 248VAL A 182 | 1.49A | 14.01 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.48A | 14.67 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 5 | LEU A 731TRP A 290MET A 242LEU A 240 | 1.57A | 14.67 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 4 / 6 | LEU C 59LEU D 103THR C 9VAL C 12 | 1.46A | 19.43 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.42A | 14.03 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.73A | 14.67 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 731LEU A 723PHE A 745VAL A 472 | 1.54A | 14.01 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | GLN C 19VAL C 22ARG C 21ILE C 68PHE D 92 | 1.61A | 16.87 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | GLN C 19VAL C 22ARG C 21ILE C 68PHE D 92 | 1.58A | 16.87 | None | ||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6m71 | NSP12NSP7NSP8 (SARS-CoV-2) | 5 / 12 | ASN A 414GLN C 18MET D 87ARG C 21VAL A 844 | 1.73A | 14.35 | None | ||
![]() | 3MNO_A_DEXA784_2 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 207TRP A 290MET A 242GLN A 210 | 1.76A | 13.80 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 786ALA A 762MET A 794CYH A 622PHE A 694 | 1.79A | 14.01 | None | ||
![]() | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6m71 | NSP12NSP7NSP8 (SARS-CoV-2) | 5 / 12 | ASN A 414GLN C 18MET D 87ARG C 21VAL A 844 | 1.74A | 14.35 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.65A | 14.03 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 4 / 6 | LEU C 17LEU D 95PHE D 92VAL C 66 | 1.57A | 19.43 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | LEU A 372LEU A 371MET B 90THR A 538ILE A 536 | 1.78A | 14.67 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.78A | 14.67 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214GLN A 210VAL A 182LEU A 178THR A 148 | 1.69A | 13.80 | None | ||
![]() | 3MNP_A_DEXA784_2 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 207TRP A 290MET A 242GLN A 210 | 1.78A | 14.12 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 240TRP A 290LEU A 245THR A 189 | 1.47A | 14.01 | None | ||
![]() | 3GN8_A_DEXA247_2 (GLUCOCORTICOIDRECEPTOR 2) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | MET A 601MET A 818PHE A 812 | 1.79A | 14.35 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214GLN A 210VAL A 182LEU A 178THR A 148 | 1.70A | 14.12 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASN B 937ALA B 714GLN B 756SER B 712LEU B 930 | 1.69A | 11.41 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | GLY A 780GLN A 902LEU A 898LEU A1031THR A 863 | 1.63A | 12.91 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASN B 910GLY B 781LEU B 776ILE B 913PHE B 909 | 1.60A | 12.91 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6nb7 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | LEU B1045LEU B 788THR B 863VAL B1015 | 0.90A | 11.41 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 6nb7 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASN C 910GLY C 781PHE C 880MET C 884ILE C 913 | 1.36A | 12.91 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6nb8 | S230 ANTIGEN-BINDING(FAB) FRAGMENT,LIGHT CHAIN (Homosapiens) | 5 / 12 | GLY L 89GLN L 42VAL L 83LEU L 15THR L 177 | 1.49A | 22.01 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6nb8 | S230 ANTIGEN-BINDING(FAB) FRAGMENT,LIGHT CHAIN (Homosapiens) | 5 / 12 | GLY L 89GLN L 42VAL L 83LEU L 15THR L 177 | 1.50A | 22.26 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6nur | NSP12 (SARSr-CoV) | 4 / 5 | LEU A 731TRP A 290MET A 242LEU A 240 | 1.56A | 14.67 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 6nur | NSP12 (SARSr-CoV) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.41A | 13.65 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6nur | NSP12NSP7NSP8 (SARSr-CoV) | 5 / 12 | ASN A 414GLY A 413LEU C 14GLN C 19LEU D 91 | 1.63A | 14.67 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6nur | NSP12 (SARSr-CoV) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.29A | 14.14 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 6nur | NSP12 (SARSr-CoV) | 5 / 12 | LEU A 786ALA A 762MET A 794CYH A 622PHE A 694 | 1.67A | 13.80 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 6nur | NSP12 (SARSr-CoV) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.36A | 14.67 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 6nus | NSP12 (SARSr-CoV) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.47A | 14.67 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 6nus | NSP12 (SARSr-CoV) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.54A | 14.67 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6nus | NSP12 (SARSr-CoV) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.50A | 14.23 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6nus | NSP12 (SARSr-CoV) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.49A | 14.14 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6nus | NSP12 (SARSr-CoV) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.48A | 14.67 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6nus | NSP12 (SARSr-CoV) | 4 / 6 | LEU A 212LEU A 146THR A 248VAL A 182 | 1.45A | 13.80 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN B 317GLY B 594GLN B 613LEU C 858THR C 739 | 1.65A | 11.46 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN B 317GLY B 594GLN B 613LEU C 858THR C 739 | 1.61A | 11.30 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 5 | LEU A 916MET A1050LEU A1049GLN A 913 | 1.54A | 11.95 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 857LEU A1004GLN A1011LEU A 767THR A 732 | 1.49A | 11.95 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | LEU B1063LEU B 806THR B 881VAL B1033 | 0.78A | 11.40 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLN C1011ARG C1014ILE B 569PHE C 855LEU C 858 | 1.61A | 10.96 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | MET A 869GLN A 787TYR A 789 | 1.54A | 11.95 | None | ||
![]() | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | LEU C 767GLY C 769GLN C1011THR C 732VAL C 860 | 1.62A | 11.02 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN B 317GLY B 594GLN B 613LEU C 858THR C 739 | 1.62A | 11.46 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | LEU B 546ASN B 544ALA B 522LEU B 517PHE B 329 | 1.76A | 11.40 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 6vw1 | ACE2SPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | MET B 323GLY F 502GLN F 506ILE B 379PHE B 356 | 1.54A | 19.97 | None | ||
![]() | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6vw1 | ACE2 (Homosapiens) | 5 / 12 | ASN B 290GLY B 286GLN B 287THR B 294VAL B 293 | 1.80A | 18.62 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 6vw1 | ACE2SPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | MET B 323GLY F 502GLN F 506ILE B 379PHE B 356 | 1.64A | 19.60 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vw1 | ACE2SPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | MET B 323GLY F 502GLN F 506ILE B 379PHE B 356 | 1.58A | 18.21 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117LEU A 93LEU A 127CYH A 143THR A 146 | 1.74A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 6 | LEU B 153LEU B 10THR B 13VAL B 144 | 1.53A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 6 | LEU B 127LEU B 122THR B 146VAL B 142 | 1.61A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.62A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.62A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.62A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 153LEU A 10THR A 13VAL A 144 | 1.61A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.61A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117LEU B 93LEU B 127CYH B 143THR B 146 | 1.76A | None | |||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 885MET A 902LEU A1049ILE A 805PHE A 802 | 1.56A | 11.88 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 885MET A 902LEU A1049ILE A 805PHE A 802 | 1.62A | 11.80 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 885MET A 902LEU A1049ILE A 805PHE A 802 | 1.62A | 11.88 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 857LEU A1004GLN A1011LEU A 767THR A 732 | 1.51A | 12.09 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN A 928GLY A 799MET A 902PHE A 797ILE A 931 | 1.75A | 12.09 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | LEU B1063LEU B 806THR B 881VAL B1033 | 0.82A | 11.35 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY C 857LEU C1004GLN C1011LEU C 767THR C 732 | 1.51A | 12.09 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN C 928GLY C 799MET C 902PHE C 797ILE C 931 | 1.76A | 12.09 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | LEU A1063LEU A 806THR A 881VAL A1033 | 0.78A | 11.35 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL A 120ARG A 190LEU A 118ILE A 235PHE A 201 | 1.64A | 11.65 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY B 885MET B 902LEU B1049ILE B 805PHE B 802 | 1.58A | 11.88 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 5 | LEU B 916MET B1050LEU B1049GLN B 913 | 1.61A | 12.09 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 885MET A 902LEU A1049ILE A 805PHE A 802 | 1.64A | 11.88 | None | ||
![]() | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | LEU A 767GLY A 769GLN A1011THR A 732VAL A 860 | 1.65A | 11.32 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6w02 | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117LEU B 93LEU B 127CYH B 143THR B 146 | 1.73A | 20.00 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w02 | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.59A | 20.08 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w02 | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.59A | 19.50 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 4 / 6 | LEU H 138LEU H 141THR H 165VAL H 163 | 1.68A | 20.00 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | MET H 100GLY H 104GLN H 6GLN L 89LEU H 45 | 1.46A | 19.84 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 3 / 3 | MET H 100GLN L 37TYR L 86 | 1.52A | 19.84 | NoneSO4 L 302 ( 4.8A)None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | LEU A6857LEU A7052THR A6891VAL A6865 | 1.74A | 20.69 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | LEU A6852PHE A6991THR A6993VAL A6995 | 1.65A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | TRP A7029PHE A7003THR A6993VAL A6995 | 1.64A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.79A | None | |||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.79A | 19.50 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.60A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.77A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.49A | 19.50 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.63A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 164LEU A 169THR A 13VAL A 144 | 1.64A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.60A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU B 127LEU B 122THR B 146VAL B 142 | 1.69A | 20.69 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU B 153LEU B 10THR B 13VAL B 144 | 1.67A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 153LEU A 10THR A 13VAL A 144 | 1.69A | 20.69 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.55A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.60A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 127LEU A 122THR A 146VAL A 142 | 1.68A | 20.69 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117LEU B 93LEU B 127CYH B 143THR B 146 | 1.75A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.55A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117LEU A 93LEU A 127CYH A 143THR A 146 | 1.71A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU B 164LEU B 169THR B 13VAL B 144 | 1.56A | None | |||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | LEU C6909GLY C6911MET C6929THR C6880PHE C6901 | 1.66A | 19.71 | None NA C7104 ( 4.1A)SAM C7105 ( 3.5A)NoneNone | ||
![]() | 1P93_B_DEXB2999_2 (GLUCOCORTICOIDRECEPTOR) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 4 / 4 | LEU D4298MET D4316GLN C6885TYR D4349 | 1.77A | 16.98 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 6 | LEU A6852PHE A6991THR A6993VAL A6995 | 1.67A | 20.78 | None | ||
![]() | 3GN8_A_DEXA247_2 (GLUCOCORTICOIDRECEPTOR 2) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 3 / 3 | MET A7045MET B4316PHE A7043 | 1.80A | 18.86 | None | ||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | LEU A6909GLY A6911MET A6929THR A6880PHE A6901 | 1.64A | 18.86 | NoneNoneSAM A7102 ( 3.5A)NoneNone | ||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | LEU C6909GLY C6911MET C6929THR C6880PHE C6901 | 1.63A | 18.86 | None NA C7104 ( 4.1A)SAM C7105 ( 3.5A)NoneNone | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 3 / 3 | MET D4316GLN C6885TYR D4349 | 1.32A | 16.98 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 6 | LEU C6852PHE C6991THR C6993VAL C6995 | 1.64A | 20.78 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 6 | TRP A7029PHE A7003THR A6993VAL A6995 | 1.68A | 20.78 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 6 | LEU A6857LEU A7052THR A6891VAL A6865 | 1.74A | 20.78 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 6 | LEU A 162TRP A 93THR A 115VAL A 165 | 1.43A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 6 | LEU B 117LEU B 125PHE B 173VAL B 165 | 1.51A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 142VAL A 98LEU A 118ILE A 151PHE A 147 | 1.54A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 6 | LEU A 117LEU A 125PHE A 173VAL A 165 | 1.57A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 185LEU A 234GLN A 237GLN A 195ILE A 222 | 1.79A | 23.88 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 6 | LEU C 117LEU C 132THR C 168VAL C 165 | 1.53A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 117LEU A 113MET A 169THR A 277ILE A 285 | 1.65A | 23.88 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU C 185LEU C 234GLN C 237GLN C 195ILE C 222 | 1.77A | 23.88 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 6 | LEU B 117LEU B 132THR B 168VAL B 165 | 1.52A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 6 | LEU C 117LEU C 125PHE C 173VAL C 165 | 1.50A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 6 | LEU A 117LEU A 132THR A 168VAL A 165 | 1.42A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w9q | 3C-LIKE PROTEINASEPEPTIDE, NSP9 FUSION (SARS-CoV-2) | 4 / 6 | LEU A 103LEU A 9THR A 109VAL A 110 | 1.58A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117LEU A 93LEU A 127CYH A 143THR A 146 | 1.75A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 153LEU A 10THR A 13VAL A 144 | 1.55A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.60A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.60A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117LEU A 93LEU A 127CYH A 143THR A 146 | 1.76A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wen | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 164LEU A 169THR A 13VAL A 144 | 1.58A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.58A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.59A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wey | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 357LEU A 214THR A 217VAL A 348 | 1.63A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wey | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 321VAL A 240LEU A 331CYH A 347THR A 350 | 1.61A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wey | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 321VAL A 240LEU A 331CYH A 347THR A 350 | 1.61A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 4 / 6 | LEU A 59LEU B 103THR A 9VAL A 12 | 1.55A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wiq | NSP8 (SARS-CoV-2) | 5 / 12 | GLN B 158VAL B 167CYH B 142THR B 141PHE B 147 | 1.80A | None | |||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 4 / 5 | LEU A 13MET B 94LEU B 95GLN B 88 | 1.63A | 16.03 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | GLN A 19ARG B 80ILE A 68PHE B 92LEU B 91 | 1.72A | 16.18 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | LEU A6852PHE A6991THR A6993VAL A6995 | 1.64A | None | |||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 3 / 3 | MET D4316GLN C6885TYR D4349 | 1.33A | 16.98 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | TRP C7029PHE C7003THR C6993VAL C6995 | 1.65A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | LEU C6852PHE C6991THR C6993VAL C6995 | 1.63A | None | |||
![]() | 1P93_B_DEXB2999_2 (GLUCOCORTICOIDRECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 4 / 4 | LEU D4298MET D4316GLN C6885TYR D4349 | 1.79A | 16.98 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY B 170GLN B 58LEU B 64GLN B 70LEU B 161 | 1.69A | None | |||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | LEU A6909GLY A6911MET A6929THR A6880PHE A6901 | 1.64A | 21.90 | None NA A7102 ( 4.2A)SFG A7103 ( 3.5A)NoneNone | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 6 | TRP C7029PHE C7003THR C6993VAL C6995 | 1.64A | None | |||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | LEU C6909GLY C6911MET C6929THR C6880PHE C6901 | 1.64A | 21.90 | None NA C7102 ( 4.2A)SFG C7103 ( 3.5A)NoneNone | ||
![]() | 1P93_B_DEXB2999_2 (GLUCOCORTICOIDRECEPTOR) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 4 / 4 | LEU D4298MET D4316GLN C6885TYR D4349 | 1.78A | 16.98 | None | ||
![]() | 3GN8_A_DEXA247_2 (GLUCOCORTICOIDRECEPTOR 2) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 3 / 3 | MET A7045MET B4316PHE A7043 | 1.79A | 21.90 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 3 / 3 | MET D4316GLN C6885TYR D4349 | 1.33A | 16.98 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 6 | LEU A6852PHE A6991THR A6993VAL A6995 | 1.65A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 6 | LEU C6852PHE C6991THR C6993VAL C6995 | 1.64A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 6 | LEU B 190LEU B 73THR B 121VAL B 183 | 1.61A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 6 | LEU A 190LEU A 73THR A 121VAL A 183 | 1.65A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.80A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.78A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.68A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.65A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.46A | 19.50 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU D 153LEU D 10THR D 13VAL D 144 | 1.62A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.64A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN C 117LEU C 93LEU C 127CYH C 143THR C 146 | 1.74A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN D 117VAL D 36LEU D 127CYH D 143THR D 146 | 1.58A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.64A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU B 127LEU B 122THR B 146VAL B 142 | 1.66A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 117LEU A 93LEU A 127CYH A 143THR A 146 | 1.70A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN B 117LEU B 93LEU B 127CYH B 143THR B 146 | 1.75A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.58A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU C 127LEU C 122THR C 146VAL C 142 | 1.65A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN D 117VAL D 36LEU D 127CYH D 143THR D 146 | 1.57A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU C 153LEU C 10THR C 13VAL C 144 | 1.66A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN C 117VAL C 36LEU C 127CYH C 143THR C 146 | 1.63A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN D 117LEU D 93LEU D 127CYH D 143THR D 146 | 1.69A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU B 153LEU B 10THR B 13VAL B 144 | 1.64A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN C 117VAL C 36LEU C 127CYH C 143THR C 146 | 1.63A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU A 127LEU A 122THR A 146VAL A 142 | 1.65A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU D 127LEU D 122THR D 146VAL D 142 | 1.63A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.59A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | LEU A6852PHE A6991THR A6993VAL A6995 | 1.59A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6962VAL A6859ARG A7081LEU A7050ILE A7005 | 1.74A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | LEU A6857LEU A7052THR A6891VAL A6865 | 1.62A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6962VAL A6859ARG A7081LEU A7050ILE A7005 | 1.72A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 6 | LEU A 17LEU B 95PHE B 92VAL A 66 | 1.61A | None | |||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 5 | LEU C 13MET D 94LEU D 95GLN D 88 | 1.75A | 16.03 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 6 | LEU C 59LEU D 103THR C 9VAL C 12 | 1.54A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 6 | LEU A 59LEU B 103THR A 9VAL A 12 | 1.57A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wqd | NSP7 (SARS-CoV-2) | 4 / 6 | LEU A 13TRP A 29LEU A 40VAL C 11 | 1.66A | None | |||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 5 | LEU A 13MET B 94LEU B 95GLN B 88 | 1.66A | 16.03 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.77A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.78A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.68A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.51A | 19.50 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.71A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | LEU A 117LEU A 113MET A 169THR A 277ILE A 285 | 1.70A | 23.88 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 4 / 6 | LEU A 117LEU A 132THR A 168VAL A 165 | 1.51A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 4 / 6 | LEU A 117LEU A 125PHE A 173VAL A 165 | 1.43A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6y2e | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.67A | 22.15 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.65A | 21.85 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 3 / 3 | MET B 264GLN B 273TYR B 237 | 1.64A | 19.50 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 5 | LEU A 272TRP A 218MET A 276GLN A 273 | 1.54A | 19.50 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.75A | 18.94 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.67A | 18.94 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.70A | 18.94 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.78A | 18.94 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.47A | 19.29 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 5 | LEU C 13MET D 94LEU D 95GLN D 88 | 1.67A | 14.18 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 6 | LEU A 59LEU B 103THR A 9VAL A 12 | 1.57A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 6 | LEU A 13TRP A 29LEU A 40VAL C 11 | 1.65A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 6 | LEU C 59LEU D 103THR C 9VAL C 12 | 1.57A | None | |||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 5 | LEU A 13MET B 94LEU B 95GLN B 88 | 1.63A | 14.18 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | GLY C 64GLN C 63VAL C 58LEU C 17THR D 84 | 1.79A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 6 | LEU C 13TRP C 29LEU C 40VAL A 11 | 1.64A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6yi3 | NUCLEOPROTEIN (SARS-CoV-2) | 5 / 12 | LEU A 119GLY A 135ARG A 67THR A 36ILE A 34 | 1.29A | 19.05 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 3 / 3 | MET B 106GLN C 43TYR C 92 | 1.46A | 19.00 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | MET H 106GLY H 110GLN H 6GLN L 95LEU H 45 | 1.47A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | MET B 106GLY B 110GLN B 6GLN C 95LEU B 45 | 1.53A | None | |||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 3 / 3 | MET H 106GLN L 43TYR L 92 | 1.51A | 19.00 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | LEU A 390LEU A 518THR A 430VAL A 382 | 1.49A | DMS A 905 (-4.9A)NoneNoneDMS A 905 (-4.3A) | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yla | HEAVY CHAIN (Homosapiens) | 4 / 6 | LEU H 142LEU H 145THR H 169VAL H 167 | 1.66A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | LEU A 387LEU A 368PHE A 338VAL A 524 | 1.54A | DMS A 905 ( 4.2A)NoneNoneNone | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | LEU E 387LEU E 368PHE E 338VAL E 524 | 1.50A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ym0 | HEAVY CHAIN (Homosapiens) | 4 / 6 | LEU H 142LEU H 145THR H 169VAL H 167 | 1.66A | None | |||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6ym0 | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 3 / 3 | MET H 106GLN L 43TYR L 92 | 1.49A | 19.53 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ym0 | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | MET H 106GLY H 110GLN H 6GLN L 95LEU H 45 | 1.51A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.69A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.72A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.75A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.73A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | LEU E 387LEU E 368PHE E 338VAL E 524 | 1.51A | None | |||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 3 / 3 | MET B 106GLN C 43TYR C 92 | 1.51A | 19.00 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | LEU A 387LEU A 368PHE A 338VAL A 524 | 1.50A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yor | IGG H CHAIN (Homosapiens) | 4 / 6 | LEU H 142LEU H 145THR H 169VAL H 167 | 1.65A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yor | IGG H CHAIN (Homosapiens) | 4 / 6 | LEU B 142LEU B 145THR B 169VAL B 167 | 1.67A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | MET H 106GLY H 110GLN H 6GLN L 95LEU H 45 | 1.47A | None | |||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 3 / 3 | MET H 106GLN L 43TYR L 92 | 1.50A | 19.00 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | MET B 106GLY B 110GLN B 6GLN C 95LEU B 45 | 1.47A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.78A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.50A | 21.41 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.76A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 153LEU C 10THR C 13VAL C 144 | 1.57A | NoneNoneEDO C 205 ( 4.3A)None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.60A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 164LEU C 169THR C 13VAL C 144 | 1.58A | NoneNoneEDO C 205 ( 4.3A)None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU E 153LEU E 10THR E 13VAL E 144 | 1.57A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117VAL C 36LEU C 127CYH C 143THR C 146 | 1.55A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU D 164LEU D 169THR D 13VAL D 144 | 1.66A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU D 153LEU D 10THR D 13VAL D 144 | 1.59A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.60A | NoneNoneEDO A 202 ( 4.8A)NoneNone | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN D 117LEU D 93LEU D 127CYH D 143THR D 146 | 1.72A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117VAL C 36LEU C 127CYH C 143THR C 146 | 1.56A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.60A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN E 117VAL E 36LEU E 127CYH E 143THR E 146 | 1.59A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 153LEU A 10THR A 13VAL A 144 | 1.61A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN E 117LEU E 93LEU E 127CYH E 143THR E 146 | 1.74A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN D 117VAL D 36LEU D 127CYH D 143THR D 146 | 1.58A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 127LEU C 122THR C 146VAL C 142 | 1.66A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.60A | NoneNoneEDO A 202 ( 4.8A)NoneNone | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN D 117VAL D 36LEU D 127CYH D 143THR D 146 | 1.58A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 164LEU A 169THR A 13VAL A 144 | 1.61A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU B 153LEU B 10THR B 13VAL B 144 | 1.59A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU B 164LEU B 169THR B 13VAL B 144 | 1.58A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117LEU B 93LEU B 127CYH B 143THR B 146 | 1.75A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN E 117VAL E 36LEU E 127CYH E 143THR E 146 | 1.59A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117LEU C 93LEU C 127CYH C 143THR C 146 | 1.70A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 127LEU C 122THR C 146VAL C 142 | 1.64A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN D 117LEU D 93LEU D 127CYH D 143THR D 146 | 1.73A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU D 164LEU D 169THR D 13VAL D 144 | 1.66A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117VAL C 36LEU C 127CYH C 143THR C 146 | 1.59A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.61A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU D 127LEU D 122THR D 146VAL D 142 | 1.63A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN E 117VAL E 36LEU E 127CYH E 143THR E 146 | 1.58A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN E 117LEU E 93LEU E 127CYH E 143THR E 146 | 1.74A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117VAL C 36LEU C 127CYH C 143THR C 146 | 1.59A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU E 153LEU E 10THR E 13VAL E 144 | 1.58A | NoneEDO E 203 ( 4.8A)NoneNone | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.60A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN A 117LEU A 93LEU A 127CYH A 143THR A 146 | 1.75A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU B 164LEU B 169THR B 13VAL B 144 | 1.50A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN D 117VAL D 36LEU D 127CYH D 143THR D 146 | 1.59A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU E 164LEU E 169THR E 13VAL E 144 | 1.64A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 153LEU C 10THR C 13VAL C 144 | 1.58A | NoneEDO B 203 (-4.6A)NoneNone | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.60A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU B 153LEU B 10THR B 13VAL B 144 | 1.56A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 153LEU A 10THR A 13VAL A 144 | 1.62A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN E 117VAL E 36LEU E 127CYH E 143THR E 146 | 1.58A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN D 117VAL D 36LEU D 127CYH D 143THR D 146 | 1.59A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117LEU B 93LEU B 127CYH B 143THR B 146 | 1.77A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117LEU C 93LEU C 127CYH C 143THR C 146 | 1.74A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 164LEU C 169THR C 13VAL C 144 | 1.53A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 127LEU A 122THR A 146VAL A 142 | 1.65A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU D 153LEU D 10THR D 13VAL D 144 | 1.61A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.61A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 164LEU A 169THR A 13VAL A 144 | 1.57A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.59A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.59A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117LEU C 93LEU C 127CYH C 143THR C 146 | 1.72A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU B 153LEU B 10THR B 13VAL B 144 | 1.58A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 153LEU A 10THR A 13VAL A 144 | 1.64A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 127LEU A 122THR A 146VAL A 142 | 1.66A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 164LEU A 169THR A 13VAL A 144 | 1.66A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.58A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117VAL C 36LEU C 127CYH C 143THR C 146 | 1.57A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 153LEU C 10THR C 13VAL C 144 | 1.61A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117LEU B 93LEU B 127CYH B 143THR B 146 | 1.74A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.58A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117VAL C 36LEU C 127CYH C 143THR C 146 | 1.57A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.45A | 19.50 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.75A | 19.50 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.70A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.68A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.76A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.73A | None | |||
![]() | 3GN8_A_DEXA247_2 (GLUCOCORTICOIDRECEPTOR 2) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | MET A 463MET A 633PHE A 313 | 1.76A | 14.35 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.42A | 14.03 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 212LEU A 146THR A 248VAL A 182 | 1.53A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214GLN A 210VAL A 182LEU A 178THR A 148 | 1.69A | None | |||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 786ALA A 762MET A 794CYH A 622PHE A 694 | 1.68A | 14.01 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 240TRP A 290LEU A 245THR A 189 | 1.53A | None | |||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.53A | 13.61 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.63A | 14.67 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 4 / 5 | LEU A 731TRP A 290MET A 242LEU A 240 | 1.55A | 14.67 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 731LEU A 723PHE A 745VAL A 472 | 1.51A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214GLN A 210VAL A 182LEU A 178THR A 148 | 1.68A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7btf | NSP7NSP8 (SARS-CoV-2) | 4 / 6 | LEU C 59LEU D 103THR C 9VAL C 12 | 1.47A | None | |||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.47A | 14.67 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.67A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.64A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.45A | 19.50 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.76A | 13.33 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 4 / 6 | LEU C 59LEU D 103THR C 9VAL C 12 | 1.47A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 673LEU A 401GLY A 671MET A 542THR A 393 | 1.72A | 14.63 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214GLN A 210VAL A 182LEU A 178THR A 148 | 1.64A | None | |||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.38A | 14.63 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.47A | 14.63 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 5 | LEU A 731TRP A 290MET A 242LEU A 240 | 1.56A | 14.63 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.74A | 13.90 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 212LEU A 146THR A 248VAL A 182 | 1.46A | None | |||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.32A | 13.90 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 731LEU A 723PHE A 745VAL A 472 | 1.48A | None | |||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 786ALA A 762MET A 794CYH A 622PHE A 694 | 1.66A | 12.69 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.42A | 13.33 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214GLN A 210VAL A 182LEU A 178THR A 148 | 1.66A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 240TRP A 290LEU A 245THR A 189 | 1.49A | None | |||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.53A | 14.63 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.60A | 14.63 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.43A | 14.63 | None | ||
![]() | 3GN8_A_DEXA247_2 (GLUCOCORTICOIDRECEPTOR 2) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | MET A 463MET A 633PHE A 313 | 1.74A | 13.09 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214GLN A 210VAL A 182LEU A 178THR A 148 | 1.66A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 673LEU A 401GLY A 671MET A 542THR A 393 | 1.63A | 14.63 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 212LEU A 146THR A 248VAL A 182 | 1.50A | None | |||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.68A | 13.33 | None | ||
![]() | 3GN8_A_DEXA247_2 (GLUCOCORTICOIDRECEPTOR 2) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | MET A 633MET A 463PHE A 694 | 1.76A | 13.09 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214GLN A 210VAL A 182LEU A 178THR A 148 | 1.65A | None | |||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.53A | 14.63 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 240TRP A 290LEU A 245THR A 189 | 1.55A | None | |||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 786ALA A 762MET A 794CYH A 622PHE A 694 | 1.68A | 12.69 | NoneNoneNoneF86 P 102 ( 4.6A)None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 731LEU A 723PHE A 745VAL A 472 | 1.55A | None | |||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.67A | 13.90 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 5 | LEU A 731TRP A 290MET A 242LEU A 240 | 1.52A | 14.63 | None |